Laddar...
Use of pioglitazone in people with type 2 diabetes mellitus with coronavirus disease 2019 (COVID-19): Boon or bane?
BACKGROUND AND AIMS: People with type 2 diabetes mellitus (T2DM) have increased morbidity and mortality due to coronavirus disease-19(COVID-19). It has been speculated that use of pioglitazone might increase such risk. The aim of our brief commentary is to review the safety of pioglitazone in people...
Sparad:
| I publikationen: | Diabetes Metab Syndr |
|---|---|
| Huvudupphovsmän: | , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Diabetes India. Published by Elsevier Ltd.
2020
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7836749/ https://ncbi.nlm.nih.gov/pubmed/32540737 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.dsx.2020.06.015 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|